Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Oral Pathology & Medicine

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jop.12270PMID 25244188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer.

  2014cited by this paper
• MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.

  2014cited by this paper
• Influence of tumour micro-environment heterogeneity on therapeutic response

  2013cited by this paper
• Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma

  2013cited by this paper
• Differentiated expression of membrane type metalloproteinases (MMP-14, MMP-15) and pro-MMP2 in laryngeal squamous cell carcinoma. A novel mechanism.

  2013cited by this paper
• Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis.

  2013cited by this paper
• Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.

  2013cited by this paper
• Epigenetic regulation of mmp-9 gene expression

  2013cited by this paper
• Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.

  2012cited by this paper
• Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes.

  2012cited by this paper
• The molecular pathogenesis of head and neck squamous cell carcinoma.

  2012cited by this paper
• Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing.

  2012cited by this paper
• An updated patent therapeutic agents targeting MMPs.

  2012cited by this paper
• Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer.

  2012cited by this paper
• Downregulation of miR-21 regulates MMP-2 expression and suppresses migration of laryngeal squamous cell carcinoma

  2012cited by this paper
• Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer*

  2010cited by this paper
• Towards a knowledge-based Human Protein Atlas

  2010cited by this paper
• The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2

  2008cited by this paper
• Influences of tumor stroma on the malignant phenotype.

  2008cited by this paper
• Matrix metalloproteinases and the regulation of tissue remodelling

  2007cited by this paper
• Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas

  2006cited by this paper
• Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.

  2005cited by this paper
• Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model

  2004cited by this paper
• Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line

  2004cited by this paper
• An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma

  2004cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Proteases in invasion: matrix metalloproteinases.

  2001cited by this paper
• Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3

  1999cited by this paper
• Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.

  1998cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper

• Proteomics analysis of serum from thymoma patients

  2023cites this paper
• The key role of microRNA-766 in the cancer development

  2023cites this paper
• A cheminformatics-biophysics correlate to identify promising lead molecules against matrix metalloproteinase-2 (MMP-2) enzyme: A promising anti-cancer target

  2023cites this paper
• Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma

  2022cites this paper
• Research progress of tight junction protein claudin-3 in hepatobiliary systemic diseases

  2022cites this paper
• Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC

  2022cites this paper
• The Role of Wnt/Beta-Catenin Pathway, SATB1 and SATB2 in Endometrial Cancer Patients

  2021cites this paper
• Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas

  2021cites this paper
• Cullin1对肺腺癌A549和H1395细胞生物学特性的影响

  2021cites this paper
• Loss of the MAF Transcription Factor in Laryngeal Squamous Cell Carcinoma

  2021cites this paper
• Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis.

  2020cites this paper
• Expressions of extracellular matrix-remodeling factors in lymph nodes from oral cancer patients.

  2020cites this paper
• The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

  2020cites this paper
• Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties

  2020cites this paper
• Relationship between Helicobacter pylori Infection and Plasmacytoid and Myeloid Dendritic Cells in Peripheral Blood and Gastric Mucosa of Children

  2019cites this paper
• Expression of ELF1, a lymphoid ETS domain‐containing transcription factor, is recurrently lost in classical Hodgkin lymphoma

  2019cites this paper
• Gliclazide Prevents 5-FU-Induced Oral Mucositis by Reducing Oxidative Stress, Inflammation, and P-Selectin Adhesion Molecules

  2019cites this paper
• Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma

  2019cites this paper
• Circulating Protein Biomarkers to Differentiate Uterine Sarcomas from Leiomyomas

  2019cites this paper
• Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions—benign adenomas and inflammatory bowel disease

  2018cites this paper
• Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma

  2018cites this paper
• TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis.

  2018cites this paper
• The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer

  2018cites this paper
• Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation

  2018cites this paper
• Vascularization Potential of Electrospun Poly(L-Lactide-co-Caprolactone) Scaffold: The Impact for Tissue Engineering

  2017cites this paper
• Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways

  2017cites this paper
• TIMP3 promoter hypermethylation contributes to the risk of renal cell carcinoma: A meta-analysis

  2017cites this paper
• Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression

  2017cites this paper
• Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors

  2017cites this paper
• Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation

  2016cites this paper
• Proteomic profiling identifies the inorganic pyrophosphatase (PPA1) protein as a potential biomarker of metastasis in laryngeal squamous cell carcinoma

  2016cites this paper
• Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma

  2016cites this paper
• Differentiated Expression of Membrane Type Metalloproteinase (MMP-14, MMP-15) and Pro-MMP2 in Laryngeal Squamous Cell Carcinoma. A Novel Mechanism: Commentary on Research Study

  2016cites this paper
• Matrix Metalloproteinases and Toll-Like Receptors in Early-Stage Oral Tongue Squamous Cell Carcinoma

  2015cites this paper
• Matrix metalloproteinases and toll-like receptors in early-stage oral tongue squamous cell carcinoma

  2015cites this paper
• TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1/CXCR4 signaling in hepatocellular carcinoma

  2015cites this paper
• Interpretation of immunohistochemistry data of tumor should consider microenvironmental factors

  2015cites this paper